2018年Mark Coventry医学博士奖:陶瓷轴承能否改善55岁以下患者全膝关节置换术的疼痛、功能、磨损或生存率?一项随机试验
该随机双盲前瞻性试验纳入110例55岁以下患者,每例患者双膝分别接受氧化锆(OxZr)与钴铬(CoCr)股骨假体,平均随访13年。结果显示两组Knee Society膝与功能评分、WOMAC、UCLA活动评分、关节活动度、影像学松动或CT骨溶解、聚乙烯磨损颗粒重量及13年无翻修生存率均无显著差异。作者认为两种假体无优劣之分,推荐常规可选用较便宜者,除非患者有个体化特殊原因(如明确的严重金属过敏)。
要点
- 平均随访13年,OxZr与CoCr假体在Knee Society膝评分(92 vs 93分)、功能评分(85 vs 85分)、WOMAC(23 vs 23分)、UCLA(6.5 vs 6.5分)及关节活动度(125° vs 127°)均无显著差异。
- 两组均无影像学松动、CT骨溶解;聚乙烯磨损颗粒重量OxZr组0.046±0.010 g vs CoCr组0.0448±0.0108 g(每1 g滑液,p=0.583)。
- 13年无翻修生存率OxZr组97%(95%CI 93-100)vs CoCr组98%(95%CI 93-100),p=0.918,无显著差异。
核心结论
- 由于CoCr与OxZr假体均未显示出优越性,作者推荐外科医生和医疗系统可合理选择较便宜的假体用于常规使用,除非个别患者有 compelling 原因(如明确的严重金属过敏)选择其中一种。
研究设计与样本
- 随机、双盲、前瞻性试验,2003年4月至2007年1月纳入110例55岁以下患者,每例患者自身对照,一膝接受OxZr股骨假体、另一膝接受CoCr股骨假体。
- 最短随访10年(平均13年,范围10-14年),2例死亡、9例失访,最终99例(198膝)纳入分析;28例男性、71例女性,平均年龄53±6岁(范围40-55岁)。
- 样本量计算:为检测Knee Society膝评分5分差异(假设SD 5分,α=0.05,β=0.80),每组需90例患者。
- Knee Society膝评分按膝获取;Knee Society功能评分、WOMAC评分和UCLA活动评分按患者术前及每次随访获取;术前及每次随访行影像学检查;最短10年(平均13年)随访时行CT扫描;终末随访用热重法和扫描电镜分析滑液中聚乙烯磨损颗粒;用Kaplan-Meier计算生存率。
主要发现
- 末次随访时Knee Society膝评分(92 vs 93分;p=0.857)、功能评分(85 vs 85分;p=1.000)、WOMAC评分(23 vs 23分;p=1.000)、UCLA活动评分(6.5 vs 6.5分;p=1.000)及膝关节活动度(125° vs 127°;p=0.365)在两组间无差异。
- 两组均无影像学松动证据,CT扫描均未见骨溶解。
- 承载面产生的聚乙烯磨损颗粒重量在OxZr股骨假体患者为每1 g滑液中0.046±0.010 g,在CoCr股骨假体患者为每1 g滑液中0.0448±0.0108 g(p=0.583)。
- 术后13年无翻修Kaplan-Meier生存率OxZr组为97%(95%CI 93-100),CoCr组为98%(95%CI 93-100)(p=0.918)。
关键数值与推荐
- 作者推荐外科医生和医疗系统可合理选择较便宜的假体用于常规使用,除非个别患者有 compelling 原因(如明确的严重金属过敏)选择其中一种。
- 证据等级:Level I,治疗性研究。
临床怎么用
- 作者推荐外科医生和医疗系统可合理选择较便宜的假体用于常规使用,除非个别患者有 compelling 原因(如明确的严重金属过敏)选择其中一种。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Methods to reduce the revision rate of total knee prostheses because of wear-related issues are important to examine, particularly because younger patients have a disproportionately high risk of revision. QUESTIONS/PURPOSES: (1) Are long-term Knee Society knee and function scores better in younger patients with an oxidized zirconium (OxZr) TKA compared with those with a cobalt-chrome (CoCr) TKA? (2) Are there differences in radiographic signs of loosening or CT findings of osteolysis between OxZr TKAs and CoCr TKAs? (3) Are there fewer polyethylene wear particles in the OxZr TKA than CoCr TKA? (4) Do the groups differ in terms of survivorship free from revision surgery at 13 years? METHODS: From April 2003 to January 2007, we enrolled 110 patients younger than 55 years of age in this randomized, double-blind, prospective trial. Each patient served as his or her own control and each received an OxZr femoral component in one knee and a CoCr femoral component in the other. The minimum followup was 10 years (mean, 13 years; range, 10-14 years); two died and nine were lost to followup before that time, leaving 99 patients (198 knees) for analysis. There were 28 men and 71 women with a mean age of 53 ± 6 years (range, 40-55 years). We obtained Knee Society knee scores for each knee, but Knee Society function scores, WOMAC scores, and UCLA activity scores were obtained for each patient preoperatively and at each followup. Additionally, we performed radiographic examination preoperatively and at each followup. At a minimum of 10 years (mean, 13 years) followup, we obtained CT scans in all patients. Polyethylene wear particles in the synovial fluid were analyzed at the final followup using thermogravimetric methods and scanning electron microscopy. Survivorship was ascertained using the Kaplan-Meier calculator. A sample size calculation determined that to detect a difference in the Knee Society knee score of 5 points, assuming a SD of 5 points, with an α = 0.05 and β = 0.80, a total of 90 patients would be needed in each group. RESULTS: At the most recent followup, the mean Knee Society knee scores (92 versus 93 points; p = 0.857), function scores (85 versus 85 points; p = 1.000), WOMAC scores (23 versus 23 points; p = 1.000), UCLA activity scores (6.5 versus 6.5 points; p = 1.000), and range of knee motion (125° versus 127°; p = 0.365) were not different between the two groups. There was no radiographic evidence of loosening and no osteolysis visible on CT scan in either group. The weight of polyethylene wear particles produced at the bearing surface was 0.046 ± 0.010 g in 1 g of synovial fluid in patients with an OxZr femoral component and 0.0448 ± 0.0108 g in patients with a CoCr femoral component (p = 0.583). Kaplan-Meier survivorship free from revision was 97% for the OxZr group (95% confidence interval [CI], 93-100) and 98% for the CoCr group (95% CI, 93-100) at 13 years after surgery (p = 0.918). CONCLUSIONS: Given the absence of demonstrated superiority of either the CoCr implant or the OxZr implant, we recommend that surgeons and healthcare systems can reasonably choose the less expensive device for routine use, unless there is some compelling reason in an individual patient to choose one over the other (such as severe, documented metal sensitivity). LEVEL OF EVIDENCE: Level I, therapeutic study.
引用
- Kim YH, Park JW, Kim JS, et al. The 2018 Mark Coventry, MD Award: Does a Ceramic Bearing Improve Pain, Function, Wear, or Survivorship of TKA in Patients Younger Than 55 Years of Age? A Randomized Trial. Clin Orthop Relat Res. 2019. PMID: 30794228. doi:10.1007/s11999.0000000000000271
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。